SCOLR, Inc. to Present at Rodman & Renshaw Techvest Global Healthcare Conference in London

[Wa Scolr via BizWire]

Techvest Global Healthcare Conference 2004

BELLEVUE, Wash.--(BUSINESS WIRE)--April 30, 2004--SCOLR, Inc.
(AMEX:DDD), a specialty pharmaceutical company, announced today that
the Company's Chief Executive Officer, Daniel O. Wilds, will deliver a
presentation on behalf of SCOLR at the Rodman & Renshaw Techvest
Global Healthcare Conference at 11:35 a.m. on Wednesday, May 12, 2004,
at the Claridge Hotel in London, England.
Wilds will provide a company overview, including a review of the
progress of targeted molecules it is developing for the pharmaceutical
and OTC markets utilizing the Company's patented, programmable
Controlled Delivery Technology (CDT(R)) oral drug delivery platform.
Based in Bellevue, Wash., SCOLR, Inc. is a biopharmaceutical
company leveraging specialized knowledge, proprietary and patented
products and technologies, such as the patented CDT Controlled
Delivery Technology platform, to introduce distinctive and novel OTC
products, prescription drugs and dietary supplements. SCOLR's CDT drug
delivery platform provides distinctive products with tangible benefits
for the consumer and competitive commercial advantages for licensees.
Partnerships with pharmaceutical, OTC and natural products industry
companies will enable SCOLR to co-develop new products and to add
value and protection to existing product franchises. For more
information on SCOLR, please call 425-373-0171 or visit
http://www.SCOLR.com/.

This press release contains forward-looking statements (statements
which are not historical facts) within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements involve risks and uncertainties, including activities,
events or developments that the company expects, believes or
anticipates will or may occur in the future. A number of factors could
cause actual results to differ from those indicated in the
forward-looking statements, including the Company's ability to
continue to market and provide its products and services and maintain
their effectiveness, the continuation of arrangements with the
Company's product development partners and customers, competition,
government regulation, and general economic conditions. Such
statements are subject to a number of assumptions, risks and
uncertainties which are described in detail in our registration
statements, reports and other filings with the Securities and Exchange
Commission. Such filings are available on our website or at
www.sec.gov. Readers are cautioned that such statements are not
guarantees of future performance and that actual results or
developments may differ materially from those set forth in the
forward-looking statements. The Company undertakes no obligation to
publicly update or revise forward-looking statements to reflect
subsequent events or circumstances.